Clinical Trial Update: A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the treatment of hormone-refractory prostate cancer in patients who have previously received chemotherapy; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostate Cancer, Cancer of Prostate | Phase 2 | Status: COMPLETED